{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:45:04Z","timestamp":1789508704361,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12640-016-9662-0","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T07:18:01Z","timestamp":1472541481000},"page":"658-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801"],"prefix":"10.1007","volume":"30","author":[{"given":"Marta","family":"Kruk-Slomka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Budzynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Slomka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Banaszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Biala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"9662_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2007-979354","volume":"2","author":"WM Abi-Saab","year":"1998","unstructured":"Abi-Saab WM, D\u2019Souza DC, Moghaddam B, Krystal JH (1998) The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 2:104\u2013109","journal-title":"Pharmacopsychiatry"},{"key":"9662_CR2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2007.05.006","volume":"182","author":"MA Akanmu","year":"2007","unstructured":"Akanmu MA, Adeosun SO, Ilesanmi OR (2007) Neuropharmacological effects of oleamide in male and female mice. Behav Brain Res 182:88\u201394","journal-title":"Behav Brain Res"},{"issue":"1","key":"9662_CR3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2010.10.007","volume":"650","author":"N Allami","year":"2011","unstructured":"Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, Dehpour AR (2011) Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Eur J Pharmacol 650(1):240\u2013248","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"9662_CR4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2014.01.039","volume":"153","author":"V Almeida","year":"2014","unstructured":"Almeida V, Peres FF, Levin R, Suiama MA, Calzavara MB, Zuardi AW, Hallak JE, Crippa JA, Ab\u00edlio VC (2014) Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain. Schizophr Res 153(1\u20133):150\u2013159","journal-title":"Schizophr Res"},{"key":"9662_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","volume":"18","author":"J Arnt","year":"1998","unstructured":"Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? a review of the evidence. Neuropsychopharmacology 18:63\u2013101","journal-title":"Neuropsychopharmacology"},{"key":"9662_CR6","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1152\/jn.2000.83.6.3287","volume":"83","author":"N Auclair","year":"2000","unstructured":"Auclair N, Otani S, Soubrie P, Crepel F (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83:3287\u20133293","journal-title":"J Neurophysiol"},{"issue":"2","key":"9662_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1101\/lm.53303","volume":"10","author":"SC Azad","year":"2003","unstructured":"Azad SC, Eder M, Marsicano G, Lutz B, Zieglg\u00e4nsberger W, Rammes G (2003) Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 10(2):116\u2013128","journal-title":"Learn Mem"},{"key":"9662_CR8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pbb.2015.02.005","volume":"131","author":"S Barzegar","year":"2015","unstructured":"Barzegar S, Komaki A, Shahidi S, Sarihi A, Mirazi N, Salehi I (2015) Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats. Pharmacol Biochem Behav 131:87\u201390","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"9662_CR9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.04.004","volume":"192","author":"G Biala","year":"2008","unstructured":"Biala G, Kruk M (2008) Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice. Behav Brain Res 192(2):198\u2013202","journal-title":"Behav Brain Res"},{"issue":"2","key":"9662_CR10","first-page":"113","volume":"60","author":"G Biala","year":"2009","unstructured":"Biala G, Kruk M, Budzynska B (2009) Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. J Physiol Pharmacol 60(2):113\u2013122","journal-title":"J Physiol Pharmacol"},{"key":"9662_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1734-1140(11)70578-3","volume":"63","author":"I Bialuk","year":"2011","unstructured":"Bialuk I, Winnicka MM (2011) AM251, cannabinoids receptors ligand, improves recognition memory in rats. Pharmacol Rep 63:670\u2013679","journal-title":"Pharmacol Rep"},{"issue":"1","key":"9662_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0306-4522(99)00483-2","volume":"95","author":"GA Bohme","year":"2000","unstructured":"Bohme GA, Laville M, Ledent C, Parmentier M, Imperato A (2000) Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95(1):5\u20137","journal-title":"Neuroscience"},{"key":"9662_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2005.02.007","volume":"79","author":"MR Broome","year":"2005","unstructured":"Broome MR, Woolley JB, Tabraham P, Johns LC, Bramon E, Murray GK, Pariante McGuire PC, Murray RM (2005) What causes the onset of psychosis? Schizophr Res 79:23\u201334","journal-title":"Schizophr Res"},{"issue":"5","key":"9662_CR14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","volume":"32","author":"V Buben\u00edkov\u00e1-Valesov\u00e1","year":"2008","unstructured":"Buben\u00edkov\u00e1-Valesov\u00e1 V, Hor\u00e1cek J, Vrajov\u00e1 M, H\u00f6schl C (2008) Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32(5):1014\u20131023","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"9662_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00213-010-1951-3","volume":"212","author":"V Buben\u00edkov\u00e1-Valesov\u00e1","year":"2010","unstructured":"Buben\u00edkov\u00e1-Valesov\u00e1 V, Svoboda J, Hor\u00e1cek J, Sumiyoshi T (2010) Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats. Psychopharmacology 212(2):267\u2013276","journal-title":"Psychopharmacology"},{"key":"9662_CR16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1734-1140(09)70036-2","volume":"61","author":"B Budzynska","year":"2009","unstructured":"Budzynska B, Kruk M, Biala G (2009) Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacol Rep 61:304\u2013310","journal-title":"Pharmacol Rep"},{"issue":"3","key":"9662_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867043456034","volume":"11","author":"ML Carlsson","year":"2004","unstructured":"Carlsson ML, Carlsson A, Nilsson M (2004) Schizophrenia: from dopamine to glutamate and back. Curr Med Chem 11(3):267\u2013277","journal-title":"Curr Med Chem"},{"issue":"3","key":"9662_CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-008-1304-7","volume":"201","author":"A Ceretta","year":"2008","unstructured":"Ceretta A, Camera K, Mello C, Rubin M (2008) Arcaine and MK- 801 make recall state-dependent in rats. Psychopharmacology 201(3):405\u2013411","journal-title":"Psychopharmacology"},{"key":"9662_CR19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1037\/0735-7044.120.5.1071","volume":"120","author":"KK Chadman","year":"2006","unstructured":"Chadman KK, Watson DJ, Stanton ME (2006) NMDA receptor antagonism impairs reversal learning in developing rats. Behav Neurosci 120:1071\u20131083","journal-title":"Behav Neurosci"},{"key":"9662_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3922\/j.psns.2010.2.013","volume":"3","author":"J Chimakurthy","year":"2010","unstructured":"Chimakurthy J, Talasila M (2010) Effects of curcumin on pentylenetetrazole-induced anxiety-like behaviors and associated changes in cognition and monoamine levels. Psychol Neurosci 3:239\u2013244","journal-title":"Psychol Neurosci"},{"issue":"2","key":"9662_CR21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0278-5846(01)00275-5","volume":"26","author":"S Da","year":"2002","unstructured":"Da S, Takahashi RN (2002) SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 26(2):321\u2013325","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9662_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0091-3057(99)00106-9","volume":"64","author":"F Ferrari","year":"1999","unstructured":"Ferrari F, Ottani A, Vivoli R, Giuliani D (1999) Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacol Biochem Behav 64:555\u2013561","journal-title":"Pharmacol Biochem Behav"},{"key":"9662_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1254\/jphs.FMJ04003X2","volume":"96","author":"M Fujiwara","year":"2004","unstructured":"Fujiwara M, Egashira N (2004) New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application. J Pharmacol Sci 96:362\u2013366","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"9662_CR24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.neuropharm.2011.01.039","volume":"60","author":"RE Hampson","year":"2011","unstructured":"Hampson RE, Miller F, Palchik G, Deadwyler SA (2011) Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 60(6):944\u2013952","journal-title":"Neuropharmacology"},{"issue":"1","key":"9662_CR25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"PJ Harrison","year":"2005","unstructured":"Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10(1):40\u201368","journal-title":"Mol Psychiatry"},{"issue":"1\u20132","key":"9662_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1101\/lm.439007","volume":"14","author":"AF Hoffman","year":"2007","unstructured":"Hoffman AF, Oz M, Yang R, Lichtman AH, Lupica CR (2007) Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem 14(1\u20132):63\u201374","journal-title":"Learn Mem"},{"key":"9662_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2011.08.006","volume":"1429","author":"M Javadi-Paydar","year":"2012","unstructured":"Javadi-Paydar M, Zakeri M, Norouzi A, Rastegar H, Mirazi N, Dehpour AR (2012) Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice. Brain Res 1429:61\u201371","journal-title":"Brain Res"},{"key":"9662_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","volume":"78","author":"DC Javitt","year":"2007","unstructured":"Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78:69\u2013108","journal-title":"Int Rev Neurobiol"},{"key":"9662_CR29","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1460-9568.2004.03285.x","volume":"19","author":"LG Khaspekov","year":"2004","unstructured":"Khaspekov LG, Brenz Verca MS, Frumkina LE, Hermann H, Marsicano G, Lutz B (2004) Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Eur J Neurosci 19:1691\u20131698","journal-title":"Eur J Neurosci"},{"key":"9662_CR30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/mol.105.016428","volume":"69","author":"SH Kim","year":"2006","unstructured":"Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA (2006) Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol Pharmacol 69:691\u2013696","journal-title":"Mol Pharmacol"},{"key":"9662_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbr.2015.12.023","volume":"301","author":"M Kruk-Slomka","year":"2016","unstructured":"Kruk-Slomka M, Biala G (2016) CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice. Behav Brain Res 301:84\u201395","journal-title":"Behav Brain Res"},{"key":"9662_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9815092","volume":"9815092","author":"M Kruk-Slomka","year":"2015","unstructured":"Kruk-Slomka M, Boguszewska-Czubara A, Slomka T, Budzynska B, Biala G (2015a) Correlations between the memory-related behavior and the level of oxidative stress biomarkers in the mice brain, provoked by an acute administration of CB receptor ligands. Neural Plast ID 9815092:1\u201316. doi: 10.1155\/2016\/9815092","journal-title":"Neural Plast ID"},{"key":"9662_CR33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","volume":"284","author":"M Kruk-Slomka","year":"2015","unstructured":"Kruk-Slomka M, Michalak A, Biala G (2015b) Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system. Behav Brain Res 284:24\u201336","journal-title":"Behav Brain Res"},{"issue":"1","key":"9662_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1574889809666140307115532","volume":"9","author":"J Kucerova","year":"2014","unstructured":"Kucerova J, Tabiova K, Drago F, Micale V (2014) Therapeutic potential of cannabinoids in schizophrenia. Recent Pat CNS Drug Discov 9(1):13\u201325","journal-title":"Recent Pat CNS Drug Discov"},{"key":"9662_CR35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0269881107077712","volume":"21","author":"CH Large","year":"2007","unstructured":"Large CH (2007) Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? J Psychopharmacol 21:283\u2013301","journal-title":"J Psychopharmacol"},{"issue":"32","key":"9662_CR36","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.2174\/138161212802884735","volume":"18","author":"R Levin","year":"2012","unstructured":"Levin R, Almeida V, Peres FF, Calzavara MB, da Silva ND, Suiama MA, Niigaki ST, Zuardi AW, Hallak JE, Crippa JA, Ab\u00edlio VC (2012) Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Curr Pharm 18(32):4960\u20134965","journal-title":"Curr Pharm"},{"issue":"2","key":"9662_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","volume":"28","author":"DA Lewis","year":"2000","unstructured":"Lewis DA, Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28(2):325\u2013334","journal-title":"Neuron"},{"issue":"1\u20133","key":"9662_CR38","first-page":"65","volume":"652","author":"JT Li","year":"2011","unstructured":"Li JT, Su YA, Guo CM, Feng Y, Yang Y, Huang RH, Si TM (2011) Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats. Eur J Pharmacol 652(1\u20133):65\u201372","journal-title":"Eur J Pharmacol"},{"key":"9662_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-2999(00)00615-4","volume":"404","author":"AH Lichtman","year":"2000","unstructured":"Lichtman AH (2000) SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 404:175\u2013179","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"9662_CR40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02246292","volume":"119","author":"AH Lichtman","year":"1995","unstructured":"Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119(3):282\u2013290","journal-title":"Psychopharmacology"},{"key":"9662_CR41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.109.156216","volume":"331","author":"Q Liu","year":"2009","unstructured":"Liu Q, Bhat M, Bowen WD, Cheng J (2009) Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-d-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. J Pharmacol Exp Ther 331:1062\u20131070","journal-title":"J Pharmacol Exp Ther"},{"issue":"5642","key":"9662_CR42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Guti\u00e9rrez SO, van der Stelt M, L\u00f3pez-Rodriguez ML, Casanova E, Sch\u00fctz G, Zieglg\u00e4nsberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302(5642):84\u201388","journal-title":"Science"},{"issue":"1","key":"9662_CR43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00441-013-1692-9","volume":"354","author":"V Micale","year":"2013","unstructured":"Micale V, Kucerova J, Sulcova A (2013) Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res 354(1):309\u2013330","journal-title":"Cell Tissue Res"},{"key":"9662_CR44","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1523\/JNEUROSCI.19-16-06795.1999","volume":"19","author":"DL Misner","year":"1999","unstructured":"Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795\u20136805","journal-title":"J Neurosci"},{"issue":"4","key":"9662_CR45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","volume":"98","author":"AR Mohn","year":"1999","unstructured":"Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98(4):427\u2013436","journal-title":"Cell"},{"issue":"1\u20132","key":"9662_CR46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02256-X","volume":"313","author":"E Murillo-Rodr\u00edguez","year":"2001","unstructured":"Murillo-Rodr\u00edguez E, Giordano M, Cabeza R, Henriksen SJ, M\u00e9ndez D\u00edaz M, Navarro L, Prosp\u00e9ro-Garc\u00eda O (2001) Oleamide modulates memory in rats. Neurosci Lett 313(1\u20132):61\u201364","journal-title":"Neurosci Lett"},{"issue":"10","key":"9662_CR47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13(10):1161\u20131169","journal-title":"Nat Neurosci"},{"issue":"3","key":"9662_CR48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0028-3908(00)00160-X","volume":"40","author":"E Palazzo","year":"2001","unstructured":"Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Rossi F, Maione S (2001) Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology 40(3):319\u2013326","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"9662_CR49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2005.12.026","volume":"397","author":"FA Pamplona","year":"2006","unstructured":"Pamplona FA, Takahashi RN (2006) WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett 397(1\u20132):88\u201392","journal-title":"Neurosci Lett"},{"key":"9662_CR50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-3-642-25761-2_14","volume":"212","author":"D Peleg-Raibstein","year":"2012","unstructured":"Peleg-Raibstein D, Feldon J, Meyer U (2012) Behavioral animal models of antipsychotic drug actions. Handb Exp Pharmacol 212:361\u2013406","journal-title":"Handb Exp Pharmacol"},{"issue":"1\u20132","key":"9662_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","volume":"140","author":"G Riedel","year":"2003","unstructured":"Riedel G, Platt B, Micheau J (2003) Glutamate receptor function in learning and memory. Behav Brain Res 140(1\u20132):1\u201347","journal-title":"Behav Brain Res"},{"key":"9662_CR52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","volume":"21","author":"D Robbe","year":"2001","unstructured":"Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 21:109\u2013116","journal-title":"J Neurosci"},{"key":"9662_CR53","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbr.2010.01.004","volume":"208","author":"L Robinson","year":"2010","unstructured":"Robinson L, Goonawardena AV, Pertwee RG, Hampson RE, Platt B, Riedel G (2010) WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res 208:584\u2013592","journal-title":"Behav Brain Res"},{"key":"9662_CR54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/npp.2011.155","volume":"37","author":"M Rodr\u00edguez-Mu\u00f1oz","year":"2012","unstructured":"Rodr\u00edguez-Mu\u00f1oz M, S\u00e1nchez-Bl\u00e1zquez P, Vicente-S\u00e1nchez A, Berrocoso E, Garz\u00f3n J (2012) The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology 37:338\u2013349","journal-title":"Neuropsychopharmacology"},{"key":"9662_CR55","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.2174\/138161212802884690","volume":"18","author":"P Roser","year":"2012","unstructured":"Roser P, Haussleiter IS (2012) Antipsychotic-like effects of cannabidiol and rimonabant: systematic review of animal and human studies. Curr Pharm Des 18:5141\u20135155","journal-title":"Curr Pharm Des"},{"key":"9662_CR56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fphar.2013.00169","volume":"4","author":"P S\u00e1nchez-Bl\u00e1zquez","year":"2014","unstructured":"S\u00e1nchez-Bl\u00e1zquez P, Rodr\u00edguez-Mu\u00f1oz M, Garz\u00f3n J (2014) The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. Front Pharmacol 4:169","journal-title":"Front Pharmacol"},{"issue":"6","key":"9662_CR57","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archneur.58.6.874","volume":"58","author":"M Shapiro","year":"2001","unstructured":"Shapiro M (2001) Plasticity, hippocampal place cells, and cognitive maps. Arch Neurol 58(6):874\u2013881","journal-title":"Arch Neurol"},{"key":"9662_CR58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","volume":"21","author":"JM Stone","year":"2007","unstructured":"Stone JM, Morrison PD, Pilowsky LS (2007) Glutamate and dopamine dysregulation in schizophrenia\u2014a synthesis and selective review. J Psychopharmacol 21:440\u20134452","journal-title":"J Psychopharmacol"},{"issue":"3","key":"9662_CR59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/lm.7.3.132","volume":"7","author":"JM Sullivan","year":"2000","unstructured":"Sullivan JM (2000) Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7(3):132\u2013139","journal-title":"Learn Mem"},{"key":"9662_CR60","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2005.01.049","volume":"380","author":"RN Takahashi","year":"2005","unstructured":"Takahashi RN, Pamplona FA, Fernandes MS (2005) The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 380:270\u2013275","journal-title":"Neurosci Lett"},{"key":"9662_CR61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02246352","volume":"126","author":"JP Terranova","year":"1996","unstructured":"Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, LeFur G, Soubrie P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126:165\u2013172","journal-title":"Psychopharmacology"},{"issue":"33","key":"9662_CR62","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","volume":"26","author":"ZX Xi","year":"2006","unstructured":"Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL (2006) Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci 26(33):8531\u20138536","journal-title":"J Neurosci"},{"issue":"3\u20134","key":"9662_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neures.2012.10.002","volume":"74","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Liu MD, Fan Y, Ding JH, Du RH, Hu G (2012) Enhanced MK-801-induced locomotion in Kir6.2 knockout mice. Neurosci Res 74(3\u20134):195\u2013199","journal-title":"Neurosci Res"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-016-9662-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-016-9662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T22:17:58Z","timestamp":1568326678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-016-9662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9662"],"URL":"https:\/\/doi.org\/10.1007\/s12640-016-9662-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}